Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR.

Pathologic prion protein (PrP(Sc)), implicated in transmissible spongiform encephalopathies, is detected by antibody-based tests or bioassays to confirm the diagnosis of prion diseases. Presently, the Western blot or an ELISA is officially used to screen the brain stem in cattle for the presence of PrP(Sc). The immuno-polymerase chain reaction (IPCR), a technique whereby the exponential amplification ability of PCR is coupled to the detection of proteins by antibodies in an ELISA format, was applied in a modified real-time IPCR method to detect ultra-low levels of prion protein. Using IPCR, recombinant hamster PrP(C) was consistently detected at 1 fg/mL and proteinase K (PK)-digested scrapie infected hamster brain homogenates diluted to 10(-8) (approximately 10-100 infectious units) was detected with a semi-quantitative dose response. This level of detection is 1 million-fold more sensitive than the levels detected by Western blot or ELISA and poises IPCR as a method capable of detecting PrP(Sc) in the pre-clinical phase of infection. Further, the data indicate that unless complete PK digestion of PrP(C) in biological materials is verified, ultrasensitive assays such as IPCR may inaccurately classify a sample as positive.

[1]  Anne McKie,et al.  Novel methods for the detection of microbial antibodies in oral fluid. , 2002, The Lancet. Infectious diseases.

[2]  S. Roels,et al.  Immuno‐Quantitative Polymerase Chain Reaction for Detection and Quantitation of Prion Protein , 2004, Journal of immunoassay & immunochemistry.

[3]  R. Joerger,et al.  High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction. , 1995, Nucleic acids research.

[4]  S. Lindquist,et al.  Chaperone-supervised conversion of prion protein to its protease-resistant form. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Cohen,et al.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein , 1995, Cell.

[6]  R. Rubenstein,et al.  A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins , 2001, Transfusion.

[7]  D. Samuel,et al.  A quantitative immuno-PCR assay for the detection of mumps-specific IgG. , 2002, Journal of immunological methods.

[8]  I. Zerr,et al.  Immunochemical determination of cellular prion proteinin plasma from healthy subjects and patients withsporadic CJD or other neurologic diseases , 2001, Transfusion.

[9]  D. Edelman,et al.  Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. , 2004, American journal of clinical pathology.

[10]  L. McShane,et al.  Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt‐Jakob disease in humans , 1999, Transfusion.

[11]  B. Permanne,et al.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.

[12]  M. Sy,et al.  Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA , 2003, The Journal of pathology.

[13]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[14]  M. Moser,et al.  Validation of a luminescence immunoassay for the detection of PrP(Sc) in brain homogenate. , 2002, Journal of virological methods.

[15]  P. Casaccia,et al.  Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie , 2005, Archives of Virology.

[16]  J. Collinge,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[17]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[18]  John Collinge,et al.  Variant Creutzfeldt-Jakob disease , 1999, The Lancet.

[19]  D Blohm,et al.  Self-assembly of DNA-streptavidin nanostructures and their use as reagents in immuno-PCR. , 1999, Nucleic acids research.

[20]  N. Hunter,et al.  Transmission of BSE by blood transfusion in sheep , 2000, The Lancet.

[21]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[22]  S. Prusiner,et al.  Further purification and characterization of scrapie prions. , 1982, Biochemistry.

[23]  P. Brown.  Transfusion medicine and spongiform encephalopathy , 2001, Transfusion.

[24]  R. Somerville,et al.  Infectivity in the blood of mice with a BSE-derived agent. , 2000, The Journal of hospital infection.

[25]  A. Burt,et al.  Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. , 1999, Journal of immunological methods.

[26]  S. Prusiner,et al.  Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice , 2002, Nature Biotechnology.

[27]  D. Edelman,et al.  Real-time PCR provides improved detection and titer determination of bacteriophage. , 2003, BioTechniques.

[28]  T. C. Chang,et al.  A modified immuno-polymerase chain reaction for the detection of beta-glucuronidase from Escherichia coli. , 1997, Journal of immunological methods.

[29]  H. Schimmel,et al.  Tests for BSE evaluated , 1999, Nature.

[30]  J. Miller,et al.  Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. , 1999, Journal of chromatography. A.

[31]  I. Macgregor,et al.  Prion protein and developments in its detection , 2001, Transfusion medicine.

[32]  J. Miller,et al.  Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. , 2000, Journal of virological methods.

[33]  Christof M Niemeyer,et al.  A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins. , 2003, Biochemical and biophysical research communications.

[34]  S. Prusiner,et al.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Niemeyer,et al.  Hybridization characteristics of biomolecular adaptors, covalent DNA--streptavidin conjugates. , 1998, Bioconjugate chemistry.

[36]  L. McShane,et al.  Similar levels of infectivity in the blood of mice infected with human‐derived vCJD and GSS strains of transmissible spongiform encephalopathy , 2003, Transfusion.

[37]  M. Eigen,et al.  Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C R Cantor,et al.  Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. , 1992, Science.

[39]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[40]  D. Samuel,et al.  Development of a quantitative immuno-PCR assay and its use to detect mumps-specific IgG in serum. , 2002, Journal of immunological methods.

[41]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[42]  A. Aguzzi,et al.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[43]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[44]  C. Niemeyer,et al.  Combination of DNA-directed immobilization and immuno-PCR: very sensitive antigen detection by means of self-assembled DNA-protein conjugates. , 2003, Nucleic acids research.

[45]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[46]  S. Trapmann,et al.  Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue , 2001, Veterinary Record.

[47]  Y G Meng,et al.  Immunopolymerase chain reaction using real-time polymerase chain reaction for detection. , 2000, Analytical biochemistry.

[48]  N. Hunter,et al.  Transmission of prion diseases by blood transfusion. , 2002, The Journal of general virology.

[49]  M. Groschup,et al.  Antigenic features of prion proteins of sheep and of other mammalian species. , 1997, Journal of immunological methods.

[50]  Failure of immunocompetitive capillary electrophoresis assay to detect disease‐specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt‐Jakob disease , 2003, Electrophoresis.

[51]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[52]  P. Brown,et al.  Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. , 2001, The Journal of laboratory and clinical medicine.

[53]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[54]  J. Ironside,et al.  Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues , 2001, The Lancet.

[55]  J. Moynagh,et al.  The Evaluation of Tests for the Diagnosis of Transmissible Spongiform Encephalopathies in Bovines. , 1999 .

[56]  C. Soto,et al.  Cyclic amplification of protein misfolding: application to prion-related disorders and beyond , 2002, Trends in Neurosciences.

[57]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.